ロード中...
Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model
Filoviruses, such as Marburg and Ebola viruses, cause severe disease in humans with high case fatality rates and are therefore considered biological threat agents. To date, no licensed vaccine or therapeutic exists for their treatment. T-705 (favipiravir) is a pyrazinecarboxamide derivative that has...
保存先:
| 出版年: | Antiviral Res |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5844847/ https://ncbi.nlm.nih.gov/pubmed/29369776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2018.01.011 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|